Download Free Sample Report

Liver Cancer Diagnostics Market, Global Outlook and Forecast 2023-2030

Liver Cancer Diagnostics Market, Global Outlook and Forecast 2023-2030

  • Published on : 15 November 2023
  • Pages :65
  • Report Code:SMR-7849189

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Liver Cancer Diagnostics market was valued at US$ 11,725 million in 2022 and is projected to reach US$ 25,980 million by 2029, at a CAGR of 8.24% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report aims to provide a comprehensive presentation of the global market for Liver Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Diagnostics. This report contains market size and forecasts of Liver Cancer Diagnostics in global, including the following market information:

  • Global Liver Cancer Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
  • Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopsy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Liver Cancer Diagnostics include Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune and Qiagen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liver Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liver Cancer Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Liver Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)

  • Biopsy
  • Endoscopy
  • Laboratory Tests
  • Imaging
  • Others
Global Liver Cancer Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Liver Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
  • Hospital
  • Clinic
  • Laboratory
Global Liver Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Liver Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
  • Key companies Liver Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Liver Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
  • Abbott Laboratories
  • BD
  • Roche Holding AG
  • Fujifilm Healthcare
  • Hologic
  • Illumina
  • Philips
  • Oncimmune
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liver Cancer Diagnostics, market overview.
Chapter 2: Global Liver Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Liver Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liver Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.